SRTA EBITDA | STRATA CRITICAL MEDICAL, INC.

STRATA CRITICAL MEDICAL, INC. (SRTA) EBITDA

2026-06-30: Basis Reported; EBITDA $3.11M*; Operating income -$5.41M; Depreciation and amortization $8.52M*.
2026-03-31: Basis Reported; EBITDA $86,000.00; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA -$3.4M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA -$3.92M*; Operating income -$5.62M; Depreciation and amortization $1.70M*.

Complete source-backed ebitda history.

Available history: 2019-09-30 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$3.11M*	-$5.41M	$8.52M*	$72.51M	4.29%*	$2.49M*	$5.69M*	(m)	(m)	$14.00M	$0.00
2026-03-31	Reported	$86,000.00	(m)	(m)	(m)	0.13%	$5.18M	$3.88M	(m)	(m)	$15.61M	$0.00
2025-12-31	Reported	-$3.4M	(m)	(m)	(m)	-5.09%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	-$3.92M*	-$5.62M	$1.70M*	$49.30M	-7.95%*	$2.90M*	-$37.30M*	(m)	(m)	(m)	$0.00
2025-06-30	Reported	-$2.87M	(m)	(m)	(m)	-6.35%	$2.23M*	-$3.06M*	(m)	(m)	$13.29M	$0.00
2025-03-31	Reported	-$3.99M	(m)	(m)	(m)	-11.09%	$2.61M	-$246.00K	(m)	(m)	$12.33M	$0.00
2024-12-31	Reported	-$4.37M	(m)	(m)	(m)	-12.02%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	-$5.81M	(m)	(m)	(m)	-16.12%	$9.31M*	$6.36M*	(m)	(m)	(m)	$0.00
2024-06-30	Reported	-$10.59M	(m)	(m)	(m)	-15.59%	$16.16M*	$8.43M*	(m)	(m)	(m)	$52.00K
2024-03-31	Reported	-$8.27M	(m)	(m)	(m)	-16.06%	$816.00K	-$15.55M	(m)	(m)	(m)	-$84.00K
2023-12-31	Reported	-$33.83M	(m)	(m)	(m)	-71.25%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	-$5.61M	(m)	(m)	(m)	-7.85%	$695.00K*	$2.02M*	(m)	(m)	(m)	$129.00K
2023-06-30	Reported	-$10.4M	(m)	(m)	(m)	-17.05%	$744.00K*	-$8.20M*	(m)	(m)	(m)	-$376.00K
2023-03-31	Reported	-$11.18M	(m)	(m)	(m)	-24.68%	$646.00K	-$16.86M	(m)	(m)	(m)	-$196.00K
2022-12-31	Reported	-$17.69M	(m)	(m)	(m)	-46.40%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$8.99M*	-$10.43M	$1.44M*	$45.72M	-19.66%*	$93.00K*	-$6.35M*	(m)	(m)	(m)	$56.00K
2022-06-30	Reported	-$8.58M*	-$9.73M	$1.16M*	$35.63M	-24.07%*	$189.00K*	-$11.61M*	(m)	(m)	(m)	$0.00
2022-03-31	Reported	-$12.55M	(m)	(m)	(m)	-47.11%	$437.00K	-$10.06M	(m)	(m)	(m)	$0.00
2021-12-31	Reported	-$9.82M*	-$10.54M	$717.00K	$24.62M	-39.89%*	$224.00K	-$6.02M	(m)	(m)	(m)	-$109.00K
2021-09-30	Reported	-$9.54M	(m)	(m)	(m)	-46.95%	$67.00K*	-$5.79M*	(m)	(m)	(m)	-$3.64M
2021-06-30	Reported	-$7.63M*	-$7.77M	$140.00K*	$12.95M	-58.92%*	$144.00K*	-$9.22M*	(m)	(m)	$790.00K	(m)
2021-03-31	Reported	-$4.1M	(m)	(m)	(m)	-44.20%	$53.00K	-$605.00K	(m)	(m)	(m)	(m)
2020-12-31	Reported	-$2.23M*	-$2.37M	$139.00K	$7.99M	-27.91%*	$33.00K	-$2.00K	(m)	(m)	(m)	$0.00
2020-09-30	Reported	-$603,000.00	(m)	(m)	(m)	-7.25%	(m)	-$127.93K*	(m)	(m)	(m)	-$26.62K
2020-06-30	Reported	(m)	-$1.48M	(m)	$3.44M	(m)	(m)	-$75.86K*	(m)	(m)	$329.00K	-$1.59K
2020-03-31	Reported	(m)	-$145.13K	(m)	(m)	(m)	(m)	-$212.27K	(m)	(m)	(m)	$152.07K
2019-09-30	Reported	(m)	-$43.05K	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$26.09K

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	-$14.17M	(m)	(m)	(m)	-7.19%	$9.60M	-$48.91M	(m)	(m)	$60.88M	$0.00
2024-12-31	Reported	-$16.56M	(m)	(m)	(m)	-11.28%	$30.86M	-$2.52M	(m)	(m)	$50.86M	$0.00
2023-12-31	Reported	-$61.01M	(m)	(m)	(m)	-27.09%	$2.11M	-$32.35M	(m)	(m)	(m)	-$1.47M
2022-12-31	Reported	-$47.8M	(m)	(m)	(m)	-32.72%	$730.00K	-$37.13M	(m)	(m)	(m)	-$772.00K
2022-09-30	Rolling	-$39.93M*	-$44.39M*	$4.46M*	$132.60M*	-30.11%*	$943.00K*	-$34.04M*	(m)	(m)	(m)	-$53.00K*
2022-06-30	Rolling	-$40.48M*	-$43.69M*	$3.21M*	$107.20M*	-37.76%*	$917.00K*	-$33.48M*	(m)	(m)	(m)	-$3.75M*
2022-03-31	Rolling	-$39.53M*	-$41.73M*	$2.19M*	$84.52M*	-46.78%*	$872.00K*	-$31.09M*	(m)	(m)	(m)	(m)
2021-12-31	Rolling	-$31.09M*	-$32.26M*	$1.17M*	$67.16M*	-46.29%*	$488.00K*	-$21.63M*	(m)	(m)	(m)	(m)
2021-09-30	Reported	-$23.5M	(m)	(m)	(m)	-46.50%	$297.00K	-$15.62M	(m)	(m)	(m)	-$3.64M
2021-09-30	Rolling	-$23.50M*	-$24.09M*	$596.00K*	$50.53M*	-46.50%*	$297.00K*	-$15.62M*	(m)	(m)	(m)	(m)
2021-06-30	Rolling	(m)	-$14.52M*	(m)	(m)	(m)	(m)	-$9.95M*	(m)	(m)	(m)	(m)
2021-03-31	Rolling	(m)	-$8.23M*	(m)	(m)	(m)	(m)	-$810.79K*	(m)	(m)	(m)	(m)
2020-12-31	Reported	(m)	-$678.49K	(m)	(m)	(m)	(m)	-$794.47K	(m)	(m)	(m)	$210.47K
2020-12-31	Rolling	(m)	-$4.15M*	(m)	(m)	(m)	(m)	-$418.06K*	(m)	(m)	(m)	$123.86K*
2020-09-30	Reported	-$9.83M	(m)	(m)	(m)	-41.96%	$377.00K	-$10.82M	(m)	(m)	(m)	$0.00
2019-09-30	Reported	-$11.07M	(m)	(m)	(m)	-35.48%	$604.00K	-$10.30M	(m)	(m)	(m)	$0.00

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
DocGo Inc. (DCGO)	United States	$0.034B	-0.25
VSEE HEALTH, INC. (VSEE)	United States	$0.003B
Agape ATP Corp (ATPC)		$0.002B
InnovAge Holding Corp. (INNV)	United States	$1.206B	-635.60
Omada Health, Inc. (OMDA)	United States	$1.207B	309.08
U S PHYSICAL THERAPY INC /NV (USPH)	United States	$1.251B	32.48
Pennant Group, Inc. (PNTG)	United States	$1.386B	39.84
Privia Health Group, Inc. (PRVA)	United States	$2.477B	115.52
GeneDx Holdings Corp. (WGS)	United States	$2.638B	-19.23
LifeStance Health Group, Inc. (LFST)	United States	$4.510B	80.86